相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
Marival Bermejo et al.
PHARMACEUTICS (2020)
Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola(R)on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b)
Bart Hens et al.
PHARMACEUTICS (2020)
Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel
Niloufar Salehi et al.
MOLECULAR PHARMACEUTICS (2020)
Re-evaluation of L(+)-tartaric acid (E 334), sodium tartrates (E 335), potassium tartrates (E 336), potassium sodium tartrate (E 337) and calcium tartrate (E 354) as food additives
Maged Younes et al.
EFSA JOURNAL (2020)
Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses
Marival Bermejo et al.
PHARMACEUTICS (2019)
Mass Transport Analysis of Bicarbonate Buffer: Effect of the CO2-H2CO3 Hydration-Dehydration Kinetics in the Fluid Boundary Layer and the Apparent Effective pKa Controlling Dissolution of Acids and Bases
Jozef Al-Gousous et al.
MOLECULAR PHARMACEUTICS (2019)
Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications
J. Al-Gousous et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development Interface
Stephanie Dodd et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Re-evaluation of phosphoric acid-phosphates - di-, tri- and polyphosphates (E 338-341, E 343, E 450-452) as food additives and the safety of proposed extension of use
Maged Younes et al.
EFSA JOURNAL (2019)
Time Scaling for In Vitro-In Vivo Correlation: the Inverse Release Function (IRF) Approach
Jean Michel Cardot et al.
AAPS JOURNAL (2018)
Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions
Marival Bermejo et al.
MOLECULAR PHARMACEUTICS (2018)
Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State
Paulo Paixao et al.
MOLECULAR PHARMACEUTICS (2018)
Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance
Jozef Al-Gousous et al.
MOLECULAR PHARMACEUTICS (2018)
Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions
Wan Sun et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Effect of Sustained Elevated Gastric pH Levels on Gefitinib Exposure
Weifeng Tang et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Assessment of drug-drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer
Yvonne Y. Lau et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
A Physiologically-Based Pharmacokinetic Modeling Approach To Predict Drug-Drug Interactions of Sonidegib (LDE225) with Perpetrators of CYP3A in Cancer Patients
Heidi J. Einolf et al.
DRUG METABOLISM AND DISPOSITION (2017)
pH-Dependent Solubility and Dissolution Behavior of Carvedilol-Case Example of a Weakly Basic BCS Class II Drug
Rania Hamed et al.
AAPS PHARMSCITECH (2016)
Trends in Oral Antibiotic, Proton Pump Inhibitor, and Histamine 2 Receptor Blocker Prescription Patterns for Children Compared With Adults: Implications for Clostridium difficile Infection in the Community
Howard S. Faden et al.
CLINICAL PEDIATRICS (2016)
Effect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteers
Jocelyn Zhou et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans
Bart Hens et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies
Chara Litou et al.
PHARMACEUTICAL RESEARCH (2016)
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) - a selective CXCR2 antagonist - in healthy adult subjects
Bruce E. Miller et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
Scientific Opinion on the re-evaluation of ascorbic acid (E 300), sodium ascorbate (E 301) and calcium ascorbate (E 302) as food additives
Fernando Aguilar et al.
EFSA JOURNAL (2015)
Scientific Opinion on the safety and efficacy of citric acid when used as a technological additive (preservative) for all animal species
Gabriele Aquilina et al.
EFSA JOURNAL (2015)
Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility
Chika Taniguchi et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Scientific Opinion on the safety and efficacy of betaine (betaine anhydrous and betaine hydrochloride) as a feed additive for all animal species based on a dossier submitted by VITAC EEIG
Gabriele Aquilina et al.
EFSA JOURNAL (2013)
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole Monitoring of Intraluminal and Plasma Drug Concentrations
Jeroen Walravens et al.
CLINICAL PHARMACOKINETICS (2011)
Biorelevant pKa (37°C) predicted from the 2D structure of the molecule and its pKa at 25°C
Na Sun et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
pH modulation: a mechanism to obtain pH-independent drug release
Pallavi Bassi et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib
Ophelia Q. P. Yin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Physiological Parameters for Oral Delivery and in Vitro Testing
Deanna M. Mudie et al.
MOLECULAR PHARMACEUTICS (2010)
Toward an In Vivo Dissolution Methodology: A Comparison of Phosphate and Bicarbonate Buffers
Jennifer J. Sheng et al.
MOLECULAR PHARMACEUTICS (2009)
Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies
L Kalantzi et al.
PHARMACEUTICAL RESEARCH (2006)
Dipyridamole bioavailability in subjects with reduced gastric acidity
H Derendorf et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Virtual computational chemistry laboratory - design and description
IV Tetko et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms
K Röhss et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution
MD Johnson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The hygroscopic properties of dicarboxylic and multifunctional acids: Measurements and UNIFAC predictions
C Peng et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2001)
分享论文
